Showing results (121-130 of 128) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 128 results.
Arthritis Research & Therapy|January 20, 2017
Optimal regimens of sulfamethoxazole-trimethoprim for chemoprophylaxis of Pneumocystis pneumonia in patients with systemic rheumatic diseases: results from a non-blinded, randomized controlled trialMasako Utsunomiya, Hiroaki Dobashi, Toshio Odani, et al.
Modern Rheumatology|February 23, 2012
Pneumocystis jirovecii pneumonia associated with etanercept treatment in patients with rheumatoid arthritis: a retrospective review of 15 cases and analysis of risk factorsMichi Tanaka, Ryoko Sakai, Ryuji Koike, et al.
Arthritis Care & Research|March 17, 2012
Time-dependent increased risk for serious infection from continuous use of tumor necrosis factor antagonists over three years in patients with rheumatoid arthritisRyoko Sakai, Yukiko Komano, Michi Tanaka, et al.
Modern Rheumatology|September 20, 2017
Pneumocystis jirovecii pneumonia associated with etanercept treatment in patients with rheumatoid arthritis: a retrospective review of 15 cases and analysis of risk factorsMichi Tanaka, Ryoko Sakai, Ryuji Koike, et al.
Annals of the Rheumatic Diseases|April 17, 2012
Drug retention rates and relevant risk factors for drug discontinuation due to adverse events in rheumatoid arthritis patients receiving anticytokine therapy with different target moleculesRyoko Sakai, Michi Tanaka, Toshihiro Nanki, et al.
Modern Rheumatology|December 16, 2021
Effectiveness and safety of subcutaneous abatacept in biologic-naïve RA patients at Week 52: A Japanese multicentre investigational study (ORIGAMI study)Naoto Tamura, Takanori Azuma, Kenta Misaki, et al.
Modern Rheumatology|December 6, 2012
Clinical characteristics and risk factors for Pneumocystis jirovecii pneumonia in patients with rheumatoid arthritis receiving adalimumab: a retrospective review and case-control study of 17 patientsKaori Watanabe, Ryoko Sakai, Ryuji Koike, et al.
Annals of the Rheumatic Diseases|April 2, 2026
Peripheral blood UBA1 variant burden predicts poor outcomes in VEXAS syndrome: a nationwide prospective studyYohei Kirino, Ayaka Maeda, Kana Higashitani, et al.
Pageof 13